Sowell Financial Services LLC Brainstorm Cell Therapeutics Inc. Transaction History

Sowell Financial Services LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 05, 2021	SELL	$3.01 - $4.01 $1,372 - $1,828	-456 Closed	0 $0
Q1 2021 May 07, 2021	SELL	$3.46 - $7.88 $48 - $110	-14 Reduced 2.98%	456 $1,000
Q4 2020 Jan 13, 2021	SELL	$3.99 - $17.73 $1,268 - $5,638	-318 Reduced 40.36%	470 $2,000
Q2 2020 Aug 13, 2020	BUY	$4.42 - $12.66 $1,379 - $3,949	312 Added 65.55%	788 $9,000
Q1 2020 May 12, 2020	BUY	$4.01 - $8.88 $1,507 - $3,338	376 Added 376.0%	476 $2,000
Q4 2019 Feb 07, 2020	BUY	$3.62 - $4.29 $362 - $429	100 New	100 $0

10.5M

160K

30.5K

Ticker BCLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,486,200
Market Cap $69.3M
Description
Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem ...

Get notified when there are updates to the investment portfolio of Sowell Financial Services LLC, based on Form 13F filings with the SEC.

Stay updated on Sowell Financial Services LLC with notifications on news.